ARTELO BIOSCIENCES, INC. - 8-K Filing

Artelo Biosciences discloses potential delisting risk due to Nasdaq's $5M MVLS Rule, which may impact its compliance status. (Items: 8.01 Other Events)

SEC EDGAR ·

Tickers: $ARTL

Read the full article at SEC EDGAR

More Regulatory news